« Previous
Next »
Drug and Alcohol Dependence
Volume 108, Issue 1
, Pages 70-76
, 1 April 2010
Association of polymorphisms of the serotonergic system with smoking initiation in Caucasians
References
- . The role of trait anxiety in nicotine dependence. J. Appl. Biobehav. Res. 1998;3:29–42
- . Low gene expression conferred by association of an allele of the 5-HT2C receptor gene with antipsychotic-induced weight gain. Am. J. Psychiatry. 2005;163:613–615
- . Association between 5-hydroxytryptamine transporter gene-linked polymorphic region and smoking behavior in Chinese males. Chin. Med. J. (Engl). 2009;122:1365–1368
- . A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in the susceptibility to affective disorders. Mol. Psych. 1996;1:453–460
- . Neurochemical individuality: genetic diversity among human dopamine and serotonin receptors and transporters. Arch. Gen. Psychiatry. 2000;57:1105–1114
- . Molecular and cellular aspects of nicotine abuse. Neuron. 1996;16:905–908
- . SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system. Neuropharmacology. 1999;38:1195–1205
- . Acute administration of amitriptyline and mianserin increases dopamine release in the rat nucleus accumbens: possible involvement of serotonin2C receptors. Psychopharmacology. 2000;150:45–51
- . Role of serotonin2c receptors in the control of brain dopaminergic function. Pharmacol. Biochem. Behav. 2002;71:727–734
- . Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostratial dopaminergic function: a combined in vivo electrophysiological and microdialysis study. Neuroscience. 1999;91:587–597
- . Association of the serotonin transporter promoter polymorphism with smoking behavior among adolescents. Am. J. Med. Genet. Part B Neuropsychiatr. Genet. 2005;135B:73–78
- . Activation of 5-HT2C receptors reduces the locomotor and rewarding effects of nicotine. Psychopharmacology. 2001;157:292–298
- . Allelic variation of human serotonin transporter gene expression. J. Neurochem. 1996;66:2621–2624
- . Tobacco use as drug addiction: the scientific foundation. Nicotine Tob. Res. 1999;1(Suppl 2):S31–35
- . 5-HT2c receptor gene polymorphisms associated with antipsychotic drug action alter promoter activity. Brain Res. 2007;1149:14–17
- . Overview of the pharmacogenomics of cigarette smoking. Pharmacogenom. J. 2007;7:81–98
- . Interaction between the serotonin transporter gene and neuroticism in cigarette smoking behavior. Mol. Psychiatry. 2000;5:181–188
- . The −759C/T polymorphism of the 5-HT2C receptor is associated with type 2 diabetes in male and female Caucasians. Pharmacogen. Genom. 2008;18:153–159
- . Association between serotonin transporter gene polymorphism and smoking among Japanese males. Cancer Epidemiol. Biomark. Prev. 1999;8:831–833
- . Validity of PCR with emphasis on variable number of tandem repeat analysis. Clin. Biochem. 2002;35:49–56
- . Association of the serotonin transporter gene with smoking behavior. Am. J. Psychiatry. 2005;162:924–930
- . Why do young women smoke? II. Role of traumatic life experience, psychological characteristics and serotonergic genes. Mol. Psychiatry. 2006;11:771–781
- . The role of serotonin transporter gene in cigarette smoking. Cancer Epidemiol. Biomark. Prev. 1998;7:253–255
- . Interacting effects of the serotonin transporter gene and neuroticism in smoking practices and nicotine dependence. Mol. Psychiatry. 2000;5:189–192
- . Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 1996;274:527–531
- . A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adults twins. Addiction. 2003;98:23–31
- . Evolutionary conserved microsatellites in the promoter region of the 5-hytroxytryptamine receptor 2C gene (HTR2C) are not associated with bipolar disorder in females. J. Neural. Transm. 2002;109:939–946
- . Effects of nicotine and mecamylamine on rat dorsal raphe neurons. Eur. J. Pharmacol. 1998;360:31–36
- . The genetic basis for smoking behavior: A systematic review and meta-analysis. Nicotine Tob. Res. 2004;6:583–597
- . Pharmacogenomics of multigenic diseases: sex-specific differences in disease and treatment outcome. AAPS Pharm. Sci. 2003;5:5:E29
- . Distribution of the serotonin 5-HT2C receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. Brain Res. Mol. Brain Res. 1994;23:163–178
- . Lack of association of the serotonin transporter gene promoter region polymorphism, 5-HTTLPR, including rs25531 with cigarette smoking and alcohol consumption. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2009;150B:575–580
- . Pharmacogenetics of treatment in first-episode schizophrenia: D3 and 5-HT2C receptor polymorphism separately associate with positive and negative symptom response. Eur. Neuropsychopharmacol. 2005;15:143–151
- . Effects of systemic nicotine on serotonin release in rat brain. Brain Res. 1993;621:311–318
- . Determination of transcription initiation sites and promoter activity of the human 5-HT2A receptor gene. Behav. Brain Res. 1996;73:59–62
- . Lack of association between serotonin transporter gene polymorphism 5-HTTLPR and smoking among polish population: a case-control study. BMC Med. Genet. 2008;9:76–83
- . Serotonin-transporter gene-linked polymorphic region: possible pharmacogenetic implications of rare variants. Psychiatr. Gen. 2006;16:153–158
- . Genomic organisation and functional expression of the gene encoding the human serotonin 5-HT2C receptor. Eur. J. Pharmacol. 1994;269:339–348
- . The serotonin transporter gene is not associated with smoking behavior. Pharmacogenomics J. 2006;6:397–400
- . Genome-wide association study of smoking initiation and current smoking. Am. J. Hum. Genet. 2009;84:367–379
- . Hardy–Weinberg disequilibrium identified genotyping error of the serotonin transporter (SLC6A4) promoter polymorphism. Psychiatr. Gen. 2006;16:31–34
- . Identification of polymorphic loci in the promoter region of the serotonin 5-HT2C receptor gene and their association with obesity and type II diabetes. Diabetologia. 2000;43:373–376
- . Serotonin transporters: implications for antidepressant drug development. AAPS J. 2005;7:421–433
PII: S0376-8716(09)00424-4
doi: 10.1016/j.drugalcdep.2009.11.015
© 2009 Elsevier Ireland Ltd. All rights reserved.
« Previous
Next »
Drug and Alcohol Dependence
Volume 108, Issue 1
, Pages 70-76
, 1 April 2010
